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Human pluripotent stem cells, including human induced pluripotent stem cells (hiPSCs), are promising
materials for regenerative medicine and cell transplantation therapy. However, tumorigenic potential of
residual undifferentiated stem cells hampers their use in these therapies. Therefore, it is important to
develop methods that selectively eliminate undifferentiated stem cells from a population of differenti-
ated cells before their transplantation. In the present study, we investigated whether plasma-activated
medium (PAM) selectively eliminated undifferentiated hiPSCs by inducing external oxidative stress.
PAM was prepared by irradiating cell culture medium with non-thermal atmospheric pressure plasma.
We observed that PAM selectively and efﬁciently killed undifferentiated hiPSCs cocultured with normal
human dermal ﬁbroblasts (NHDFs), which were used as differentiated cells. We also observed that un-
differentiated hiPSCs were more sensitive to PAM than hiPSC-derived differentiated cells. Gene
expression analysis suggested that lower expression of oxidative stress-related genes, including those
encoding enzymes involved in hydrogen peroxide (H2O2) degradation, in undifferentiated hiPSCs was
one of the mechanisms underlying PAM-induced selective cell death. PAM killed undifferentiated hiPSCs
more efﬁciently than a medium containing the same concentration of H2O2 as that in PAM, suggesting
that H2O2 and various reactive oxygen/nitrogen species in PAM selectively eliminated undifferentiated
hiPSCs. Thus, our results indicate that PAM has a great potential to eliminate tumorigenic hiPSCs from a
population of differentiated cells and that it may be a very useful tool in regenerative medicine and cell
transplantation therapy.
© 2016, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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Human pluripotent stem cells (hPSCs), including human em-
bryonic stem cells (hESCs) and human induced pluripotent stem
cells (hiPSCs), are potential sources of cells for use in regenera-
tive medicine, drug screening, and cell transplantation therapy
[1e4]. In 2014, the ﬁrst human trial on hiPSC-derived retinal
pigment epithelium [5] was performed by the Riken Center for
Developmental Biology, Kobe, Japan. Thus, innovative therapy by
using hiPSCs-derived differentiated cells is becoming an
increasingly realistic prospect. However, hPSCs-based therapy
is associated with some risks such as tumor and teratoma
formation because of the residual tumorigenic potential ofsting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
Fig. 1. Quantitative effects of PAM on undifferentiated 201B7 hiPSCs and differentiated
NHDFs. PAM was diluted to an optimal concentration by using fresh Stemﬁt AK03
medium containing A, B, and C solutions and was added each wells (n ¼ 3). After 24 h,
cell viabilities (%) were evaluated using the Cell Counting Kit-8 by following the
manufacturer's instructions. Red bars denote NHDFs, and blue diagonal bars denote
201B7 hiPSCs. The means ± SD of three experiments are shown; ***p < 0.005.
Fig. 2. Effects of cell density or PAM volume on the viability of undifferentiated 201B7
hiPSCs. (A) HiPSCs were seeded at densities of 2.0  104, 1.0  104, and 5.0  103 cells/
well and were treated with 90 mL of 8-fold diluted PAM. (B) HiPSCs were seeded at a
density of 1.0  104 cells/well and were treated with 60, 90, and 120 mL of 8-fold
diluted PAM. After 24 h, cell viability (%) was evaluated using the Cell Counting Kit-
8 in accordance with the manufacturer's instructions. The means ± SD of three ex-
periments are shown.
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differentiated cells [6]. Therefore, it is important to develop
methods that selectively eliminate undifferentiated cells before
transplanting differentiated cells to realize the safety of hPSC-
based therapy.
Several methods have been developed to eliminate residual
hPSCs from a population of differentiated cells, including induc-
tion of selective cell death by using cytotoxic antibodies [7,8], use
of lectin-conjugated cytotoxic proteins [9], chemical inhibitors
[10e12], use of conditionally replicating adenoviruses [13], se-
lective separation by performing cell sorting with hPSC-speciﬁc
antibodies [14], and metabolic properties [15]. However, these
methods are associated with some limitations with respect to
speciﬁcity, cost, efﬁcacy, safety, and throughput. Therefore, alter-
native novel methods based on different mechanisms should be
developed.
Plasma is an ionized gas containing positive and negative ions,
radicals, electrons, uncharged (neutral) atoms and molecules, and
UV photons [16]. In recent years, non-thermal atmospheric pres-
sure plasma (NEAPP) has been used in various biological applica-
tions [17e19] and has emerged as a novel technology for medical
applications such as cancer therapy. Moreover, both direct irradi-
ation of cancer cells and indirect irradiation of medium or water
with NEAPP affects cancer cells because of the presence of various
reactive oxygen species (ROS), including superoxide anions, hy-
droxyl radicals, singlet oxygen, nitric oxide (NO), nitrate/nitrite
(NOx), hydrogen peroxide (H2O2), and other uncertain species.
Plasma-activated medium (PAM) or plasma-activated water exerts
cytotoxic effects on various cancer cells compared with those on
normal cells [20e22] but exerts a curative effect on age-related
macular degeneration [23]. Moreover, recent studies have sug-
gested that PAM or plasma-activated water is a new tool for
treating various diseases and can be used in various biological
researches.
Compared to differentiated cells, hPSCs respond differently to
oxidative stress [24,25]. Prigione et al. [25] reported that (1)
expression levels of some oxidative stress-related geneswere lower
in hPSCs than in differentiated cells and that (2) expression level of
glutathione peroxidase-1 (GPX1), the most abundant glutathione
peroxidase isozyme in mammalian cells [26], signiﬁcantly
decreased in hPSCs compared with that in differentiated cells.
Therefore, we investigated whether hPSCs could be selectively
eliminated by using PAM because it induces oxidative stress in cells.
Results of the present study indicated that PAM could be a potential
tool for eliminating residual hPSCs present in a population of
differentiated cells.
2. Results
2.1. Differential sensitivities of undifferentiated and differentiated
cells toward PAM
To determine whether PAM eliminated undifferentiated cells,
we investigated the sensitivities of undifferentiated 201B7 hiPSCs
and NHDFs toward PAM. Different dilutions of PAM were added to
hiPSC and NHDF cultures, and viabilities of these cells were eval-
uated after 24 h. Undifferentiated hiPSCs were completely killed
after treatment with 1- to 16-fold diluted PAM (Fig. 1). In contrast,
NHDFs were not killed even after treatment with 8-fold diluted
PAM (cell viability, 97.6% ± 10.4%). These results indicated that
undifferentiated hiPSCs were more sensitive to PAM than NHDFs
and suggested that PAM could selectively eliminate undifferenti-
ated cells.
Since we previously reported that the effect of PAM varied with
cell density or its volume, using a cancer cell line [21], weinvestigated whether these parameters affected the sensitivity of
hiPSCs to PAM. The viability of iPSCs varied with cell density
(Fig. 2A), with values of 113.9% ± 7.1% for 2.0  104 cells/well,
81.9% ± 5.8% for 1.0  104 cells/well, and 42.0% ± 2.8% for
5.0  103 cells/well. The viability of iPSCs also varied with PAM
volume (Fig. 2B), with values of 96.7% ± 9.0% for 60 mL, 81.9% ± 5.8%
for 90 mL, and 51.0% ± 12.3% for 120 mL. Considering these results, in
subsequent experiments with different experimental conditions,
the effective dilution ratio of PAM for each experiment was ob-
tained and used to eliminate undifferentiated hiPSCs.
2.2. Selective elimination of undifferentiated cells by PAM
We next investigated whether PAM selectively eliminated un-
differentiated hiPSCs. We cocultured undifferentiated hiPSCs and
NHDFs. HiPSCs were ﬁrst seeded in a multi-well plate and were
cultured. After 48 h, ﬂuorescently labeled NHDFs were seeded into
the same plate and were cultured for 24 h. Next, the cells were
treated with PAM for 24 h, stained with PI, and observed under a
ﬂuorescence microscope (Fig. 3). We observed that hiPSCs that
were treated with undiluted PAM detached from the surface and
Fig. 3. Effects of PAM on undifferentiated 201B7 hiPSCs and differentiated cells NHDFs in a coculture. 201B7 hiPSCs were seeded in a 12-well plate. After 48 h, NHDFs stained with
CellTracker Green were seeded in the 12-well plate containing hiPSCs. After 24 h, undiluted or 4-fold diluted PAM was added to the plate and the cells were incubated for 6 h. Next,
PAM was removed, and the cells were stained with PI solution and were observed under a ﬂuorescence microscope. (A ~ D) Cells treated with undiluted PAM, (E ~ H) cells treated
with 4-fold diluted PAM, and (I ~ L) cells not treated with PAM. (A) The ﬁeld of hiPSCs attachment before PAM treatment is indicated by an asterisk. (E and I) Arrow heads indicate
hiPSCs.
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Most of the NHDFs treated with undiluted PAM appeared shrunken
and were stained by PI (Fig. 3AeD). A proportion of hiPSCs that
were treated with 4-fold diluted PAM were positively stained by PI
and appeared shrunken (Fig. 3EeH). In contrast, NHDFs treated
with 4-fold diluted PAM were not positive for PI (Fig. 3EeH), and
proliferated normally to reach conﬂuence (Fig. S1). HiPSCs and
NHDFs without PAM treatment did not shrink or stain positively
with PI (Fig. 3IeL). Considering these results, we concluded that
undiluted PAM could kill both undifferentiated hiPSCs and NHDFs
(Fig. 3AeD), whereas 4-fold diluted PAM selectively kills hiPSCs
without exerting any apparent toxic effects on differentiated cells
(Fig. 3EeH).
2.3. Evaluation of the elimination ability of PAM in a coculture by
performing ﬂow cytometry
Because PAM treatment of a coculture containing undifferenti-
ated hiPSCs and NHDFs selectively eliminated the undifferentiated
cells (Fig. 3), we evaluated the elimination ability of PAM in a
coculture by performing ﬂow cytometry. Undifferentiated hiPSCs
and ﬂuorescently labeled NHDFs were cocultured at different ratios
(initial hiPSCs:NHDFs ratios were 1:2, 1:4, and 1:8) and were
treated with 4-fold diluted PAM. After 48 h, the cells were collected
and whole-cell populations containing different ratios of the 2 cell
types were analyzed by performing ﬂow cytometry. Results of ﬂow
cytometry showed that in control experiments, whole-cell pop-
ulations containing initial hiPSC:NHDF ratios of 1:2, 1:4, and 1:8,
contained 25.6%, 56.0%, and 83.2% NHDFs (Fig. 4, middle). Further,
whole-cell populations containing initial hiPSC:NHDF ratios of 1:2,
1:4, and 1:8 contained 97.7%, 98.7%, and 98.6% NHDFs aftertreatment with 4-fold diluted PAM (Fig. 4, bottom). These results
indicated that undifferentiated hiPSCs were almost completely
eliminated from thewhole-cell populations after treatment with 4-
fold diluted PAM (Fig. 4, bottom). In addition, these results indi-
cated that PAM was efﬁcient in selectively eliminating undifferen-
tiated hiPSCs from a coculture.
2.4. Differential sensitivity of undifferentiated hiPSCs and hiPSC-
derived differentiated cells toward PAM
In the above experiments, NHDFs were used as differentiated
cells (Figs. 1, 3 and 4). We also determined the effect of PAM on
hiPSC-derived differentiated cells. HiPSC differentiation was
induced by treatment with retinoic acid (RA) for 9 days [9,11]. The
resulting differentiated cells and undifferentiated hiPSCs were
cocultured and were treated with PAM (Fig. 5A). Cells treated with
RA for 9 days were not stained with FITCerBC2LCN, a ﬂuorescent
lectin probe, that was used to detect undifferentiated cells (data not
shown). Most undifferentiated hiPSCs (not treated with RA) were
killed after treatment with 16-fold diluted PAM (Fig. 5B [ieiv]). In
contrast, most hiPSC-derived differentiated cells survived after
treatment with the same dilution of PAM (Fig. 5B [veviii]). These
results indicated the potential of PAM for use in the actual differ-
entiation process of the hiPSCs to other cell types such as car-
diomyocytes and hepatocytes.
2.5. Mechanism underlying PAM-induced elimination of
undifferentiated hiPSCs
To determine the sensitivity of undifferentiated hiPSCs to PAM
compared with that of NHDFs, we evaluated the expression levels
Fig. 4. Selective elimination of hiPSCs by PAM in a mixed-cell population. Varying numbers of 201B7 hiPSCs were cultured. After 48 h, NHDFs stained with CellTracker Green were
seeded in a plate containing hiPSCs. After 24 h, 4-fold diluted PAM was added to the plate and the cells were incubated for 48 h. Next, PAM was removed, and the cells were washed
with PBS. The cells were collected, and ﬂow cytometry data were acquired.
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NHDFs. We selected 4 genes, namely, superoxide dismutase (SOD),
GPX1, catalase (CAT), and ataxia telangiectasia mutated (ATM). SOD,
GPX1, and CATare involved in ROS generation and degradation. ROS
is one of the main components of PAM [20e23]. ATM functions as
DNA-repairing protein in human cells exposed to various stresses
(e.g., ROS) [27]. Cells lacking ATM are hypersensitive to oxidative
stress [28]. Expression level of SOD was similar in undifferentiated
hiPSCs and NHDFs. However, expression levels of GPX1, ATM, and
CAT were approximately 0.63, 0.46, and 0.09, respectively, in un-
differentiated hiPSCs compared with those in NHDFs (Fig. 6AeD).
These results suggested that low expression levels of oxidative
stress-related genes in undifferentiated hiPSCs contributed to their
selective elimination by PAM.H2O2 is one of the main components of PAM [21]. Because
expression levels of oxidative stress-related genes, including those
encoding enzymes involved in H2O2 degradation, were low in un-
differentiated hiPSCs (Fig. 6BeC), sensitivity of these cells to PAM
was compared with their sensitivity to a medium containing the
same concentration of H2O2 as that in PAM. We measured H2O2
concentration in PAM (464 ± 59 mM) and prepared a medium
containing 465 mM H2O2. Approximately 92.1% undifferentiated
hiPSCs were killed after treatment with PAM, whereas only 57.4%
undifferentiated hiPSCs were killed after treatment with the H2O2-
containing medium (Fig. 6E). These results suggested that H2O2 as
well as various reactive oxygen nitrogen species (RONS) present in
PAM contributed to the selective elimination of undifferentiated
hiPSCs.
Fig. 5. Effect of PAM on the viability of undifferentiated 201B7 hiPSCs and RA-induced differentiated 201B7 hiPSCs. 201B7 hiPSCs were cultured in a medium containing 5 mM RA for
9 days. Undifferentiated 201B7 hiPSCs were seeded in a dish 24 h before PAM treatment. After 9 days of RA treatment, 16-fold diluted PAM was added to the dish and the cells were
incubated for 24 h. Next, PAM was removed, and the cells were washed with PBS. The cells were then stained with calcein-AM and PI and were observed under a ﬂuorescence
microscope. (A) Schematic representation of the experimental procedure, and (B) experimental results. (i) Phase-contrast image of undifferentiated hiPSCs. (ii) Calcein-AM staining
image of undifferentiated hiPSCs. (iii) PI staining image of undifferentiated hiPSCs. (iv) Overlay image of ieiii. (v) Phase-contrast image of differentiated hiPSCs. (vi) Calcein-AM
staining image of differentiated hiPSCs. (vii) PI staining image of differentiated hiPSCs. (viii) Overlay image of vevii. Scale bar, 200 mm.
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In this study, we showed that PAM containing RONS eliminated
undifferentiated hiPSCs selectively and efﬁciently. We observed
that 201B7 hiPSCs were more sensitive to lower concentration of
PAM than NHDFs (Fig. 1). In addition, we observed that PAM
selectively eliminated undifferentiated hiPSCs cocultured with
NHDFs (Fig. 3). We performed ﬂow cytometry to conﬁrm that PAM
had very high ability to eliminate undifferentiated hiPSCs (Fig. 4). In
addition, we showed that the sensitivity of the differentiated cells
and hiPSC-derived differentiated cells were apparently different,
showing the potential of PAM for use in the actual process (Fig. 5).
To the best of our knowledge, this is the ﬁrst study to report the use
of differential response of undifferentiated hiPSCs and differenti-
ated cells to oxidative stress to selectively eliminate undifferenti-
ated hiPSCs.
Expression levels of oxidative stress-related genes such as GPX1,
CAT, and ATMwere lower in undifferentiated hiPSCs than in NHDFs
(Fig. 6BeD). Prigione et al. also reported that expression levels of
oxidative stress-related genes were lower in hiPSCs than in iPSC-
derived ﬁbroblasts [24]. These results suggested that hiPSCs had
lower ability to neutralize external oxidative stress than normal
cells. This might be one of the reasons for the higher sensitivity of
undifferentiated hiPSCs to external oxidative stress such as thatinduced by PAM than normal cells. PAM selectively eliminates
cancer cells [20,21]. Activities of SOD and CAT are lower in cancer
cells (e.g., colon and liver cancer cells) than in normal cells [29],
which was similar to that observed in hiPSCs. Therefore, mecha-
nisms underlying PAM-induced death of hiPSCs and cancer cells
may be similar. Intracellular ROS concentration is higher in cancer
cells than in normal cells because of the highmitochondrial activity
in cancer cells [29]. However, undifferentiated cells such as hESCs
do not show high mitochondrial activity [24]. Therefore, further
studies should be performed to understand in detail the mecha-
nisms underlying PAM-induced selective death of hiPSCs. An un-
derstanding of mechanisms underlying PAM-induced cancer cell
death may provide some insights on mechanisms underlying PAM-
induced death of hiPSCs.
PAM killed undifferentiated cells more efﬁciently than the me-
dium containing the same concentration of H2O2 (Fig. 6E), which
was similar to that observed with cancer cells [21]. PAM contains
relatively short-lived superoxide anions, hydroxyl radicals, singlet
oxygen, and NO; long-lived species such as H2O2 and NOx; and
other uncertain species [20e23]. Therefore, the ability of PAM to
effectively eliminate undifferentiated cells may be attributed to
these components. Moreover, mechanisms underlying cell death
induced by PAM are different from those underlying cell death
induced by H2O2-containing medium. Adachi et al. reported that
Fig. 6. Differences in the mRNA expression of oxidative stress-related genes between undifferentiated hiPSCs and differentiated NHDFs. Total RNAs of NHDFs (red bars) and hiPSCs
(blue diagonal bars) were extracted from 4-day cultures, and mRNA levels were evaluated by performing real-time PCR. The mRNA levels of oxidative stress-related genes are
expressed relative to those of GAPDH. Relative mRNA levels in hiPSCs are represented as “1”. (A) SOD, (B) GPX1, (C) CAT, and (D) ATM (p ¼ 0.07). (E) H2O2-containing medium was
prepared by using the same concentration of H2O2 as that in PAM. H2O2 concentration in PAMwas measured using Amplite™ Fluorimetric Hydrogen Peroxide Assay Kit by following
the manufacturer's instructions. PAM or H2O2-containing medium was added to each well containing 201B7 hiPSCs (n ¼ 3). After 24 h, cell viabilities (%) were evaluated using the
Cell Counting Kit-8 by following the manufacturer's instructions. Each bar represents mean ± SD (n ¼ 3); *p < 0.1, **p < 0.05, ***p < 0.005.
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used to visualize plasma membrane injury, increased after treat-
ment with PAM but not after treatment with H2O2-containing
medium [21]. In addition, accumulation of YO-PRO-1 ﬂuorescence,
which is used to determine plasma membrane permeability due to
apoptotic membrane injury, increased after treatment with PAM
but not after treatment with H2O2-containing medium [21]. These
results suggested that mechanisms underlying PAM-induced deathof undifferentiated hiPSCs are partially different from those un-
derlying H2O2-containing medium-induced cell death.
The effective PAM dilution ratios differed between experi-
ments using different cell numbers (Figs. 1, 3 and 4). In mono-
culture experiments, 4-fold diluted PAM killed both hiPSCs and
NHDFs, whereas 8- and 16-fold diluted PAM killed hiPSCs but not
NHDFs (Fig. 1). In co-culture experiments, 4-fold diluted PAMwas
effective for selectively eliminating hiPSCs from NHDFs (Figs. 3
R. Matsumoto et al. / Regenerative Therapy 5 (2016) 55e63 61and 4). Previously, we reported that the effect of PAM varied with
cell density or PAM volume using A549 cells (a human lung
adenocarcinoma epithelial cell line) [21]. In the present study, we
used undifferentiated hiPSCs and showed that cell viability
differed with different cell densities or PAM volumes (Fig. 2).
Considering these results, the optimization of PAM dilution and
volume is necessary to eliminate residual hiPSCs during the dif-
ferentiation process (to different cell types) for regenerative
therapy.
PAM treatment is associated with some advantages. First, PAM
is easy to use and has low manufacturing cost because it needs to
be irradiated for only a few minutes. Second, PAM retains its
elimination ability even when stored at less than 80 C [21].
Third, PAM may induce no or minimal antigenicity because it
contains small chemical compounds such as H2O2. In the present
study, we used a commercially available clinical grade medium
(Stemﬁt AK03) to prepare PAM [30] and successfully eliminated
undifferentiated hiPSCs. Thus, our results suggest that PAM can be
used clinically in the future to eliminate potentially tumorigenic
undifferentiated hPSCs from a population of differentiated cells
before transplantation.
However, for realizing clinical use of PAM for eliminating
tumorigenic hiPSCs, inﬂuence of PAM treatment not only to the
undifferentiated hiPSCs but also to the hiPSC-derived differentiated
cells should be examined in detail. To date, several studies have
examined the effects of PAM on differentiated normal cells and
have shown that PAM exerts less harmful effects on these cells.
Tanaka et al. [22] investigated the effects of PAM on glioblastoma
cells and normal astrocytes and observed that PAM killed glio-
blastoma cells through PI3K/PTENeAKT pathway without affecting
normal astrocytes. Moreover, NEAPP did not affect the essential
components in the medium used for culturing these cells [22]. Torii
et al. [20] showed that WI-38 human ﬁbroblasts are more resistant
to PAM than gastric cancer cells. We also observed that NHDFs grew
normally after treatment with PAM concentration that killed un-
differentiated hiPSCs (Fig. S1). However, because ROS in PAMmight
induce DNA damage, including small or bulky modiﬁcations in
bases as well as single- and double-stranded breaks [29], effect of
PAM on the genomes of normal cells should be assessed very
carefully.
In conclusion, we showed that PAM treatment selectively
eliminated residual hiPSCs in a population of differentiated cells.
Therefore, this novel approach may serve as a promising tool in
regenerative medicine and cell transplantation therapy.
4. Materials & methods
4.1. Cell culture
HiPSC (201B7 [31]) was provided by the RIKEN BRC through the
Project for Realization of Regenerative Medicine and the National
Bio-Resource Project of the MEXT, Japan. HiPSCs were cultivated in
0.5 mg/cm2 laminin-511 E8 (iMatrix-511, 381-07363; Wako, Japan)-
coated 25-cm2 cell culture ﬂask (430639; Corning, New York, USA)
containing Stemﬁt AK03 (Ajinomoto, Japan). These cells were
passaged after dissociation into single cells with TrypLE Select CTS
(A12859-01; Life Technologies, California, USA) [30]. For passaging,
25-cm2 ﬂasks were coated with laminin-511 E8 for 1 h at 37 C in a
CO2 incubator. Laminin-511 E8 solutionwas dilutedwith PBS before
use. After coating, PBS solution was removed and 5 mL Stemﬁt
AK03 medium containing rock inhibitor (Y-27632; ﬁnal concen-
tration, 10 mM; Wako) was added to the ﬂask. The ﬂask was incu-
bated at 37 C in a CO2 incubator until the cells were seeded. HiPSCs
were dissociated into single cells by using 0.5 TrypLE Select (1:1
dilution of 1 TrypLE Select and 0.5 mM EDTA/PBS) for 4 min at37 C in a CO2 incubator. After trypsinization, trypsin solution was
removed and the cells were washed with 4 mL PBS. PBS was then
removed, and the cells were scraped using 2.5 mL Stemﬁt AK03 and
were dissociated into single cells by pipetting them 10 times. The
cells were counted using TC20™ Automated Cell Counter (Bio-Rad,
California, USA) and were seeded (3.25  104 cells/ﬂask). On the
following day, the cultivation medium was replaced with a fresh
medium (Stemﬁt AK03) to remove the rock inhibitor. The medium
was changed every alternate day thereafter. The next passage was
conducted when the cells reached 80%e90% conﬂuency.
NHDFs (KF-4109; Kurabo, Japan) were cultivated in a 75-cm2 cell
culture ﬂask (658170; Greiner Bio-one, Frickenhausen, Germany)
containing DMEM (08458-16; Nacalai Tesque, Japan) supplemented
with 10% fetal bovine serum (FBS; Life Technologies) and 1% pen-
icillinestreptomycin (PS; Life Technologies). For passaging, NHDFs
cultured in 75-cm2 ﬂask were washed twice with 5 mL PBS and
were dissociated using 0.05% trypsin/EDTA (3mL) for 1 min at 37 C
in a CO2 incubator. The cells were counted using TC20™ Automated
Cell Counter and were seeded. The medium was changed every
alternate day. The next passage was conducted when the cells
reached 80%e90% conﬂuency. Cells passaged for 6e10 times were
used in subsequent experiments.
4.2. Preparation of PAM
NEAPP irradiation system used in this study included a power
controller/gas ﬂow regulator, argon (Ar) gas cylinder, and plasma
source head [21]. Flow rate of Ar gas was set at 2 standard liters/
min. PAMwas prepared in 60-mm culture dishes (430166; Corning)
by exposing plasma to 8mL Stemﬁt AK03medium lacking Stemﬁt B
and C solutions. The distance (L) between the plasma source and
the surface of the mediumwas ﬁxed at 3 mm. The duration for PAM
irradiation was 5 min. The prepared PAM was preserved in a
refrigerator at 80 C until further use. Stemﬁt B and C solutions
were preserved in a refrigerator at 30 C until further use. H2O2
concentration in PAM was measured using Amplite Fluorimetric
Hydrogen Peroxide Assay Kit (11502; AAT Bioquest, Sunnyvale,
USA) at near-infrared ﬂuorescence by following the manufacturer's
instructions. Stemﬁt AK03 medium containing equivalent concen-
tration of H2O2 was prepared using the concentration of H2O2 in
PAM andwas preserved in a refrigerator at30 C until further use.
4.3. Cell cytotoxicity assay
Ninety-six-well plates (655180; Greiner Bio-one) were coated
with 0.5 mg/cm2 laminin-511 E8 for 1 h at 37 C in a CO2 incubator,
as described above. HiPSCs or NHDFs were seeded (1.0  104 cells/
well) in 200 mL Stemﬁt AK03 medium containing the rock inhibitor
(ﬁnal concentration, 10 mM) and were incubated for 24 h at 37 C in
a CO2 incubator. On the following day, PAM, H2O2-containing me-
dium, and Stemﬁt B stock solution were thawed in a water bath at
37 C for 90 s. Stemﬁt C stock solution was thawed at room tem-
perature. After thawing, 250 mL Stemﬁt B solution and 5 mL Stemﬁt
C solutionweremixed with 1mL PAM or H2O2-containingmedium.
The mixed PAM solution or H2O2-containing medium was diluted
to an optimal concentration. The cultivation medium in the 96-well
plates was removed, and 150 mL mixed PAM solution was added to
each well. The plates were then incubated for 24 h at 37 C in a CO2
incubator. After incubation, cell viability was determined using Cell
Counting Kit-8 (347-07621; Dojindo, Japan) by following the
manufacturer's instructions.
To investigate the effects of cell density on the viability of
hiPSCs, cells were seeded (2.0  104, 1.0  104, and 5.0  103 cells/
well) and treated with 90 mL of 8-fold diluted PAM. To investigate
the effects of PAM volume on the viability of hiPSCs, cells were
R. Matsumoto et al. / Regenerative Therapy 5 (2016) 55e6362seeded (1.0  104 cells/well) and treated with 60, 90, and 120 mL of
8-fold diluted PAM.
4.4. Selective killing of undifferentiated cells in a coculture
Twelve-well plates (665180; Greiner Bio-one) were coated with
0.5 mg/cm2 laminin-511 E8 for 1 h at 37 C in a CO2 incubator, as
described above. Next, 201B7 hiPSCs were seeded (5.45  104 cells/
well) in the Stemﬁt AK03 medium containing the rock inhibitor
(ﬁnal concentration, 10 mM) and were incubated for 24 h at 37 C in
a CO2 incubator. On the following day, the medium was replaced
with a fresh medium to remove the rock inhibitor and the cells
were incubated further for 24 h. On the third day, NHDFs were
stained with 5 mM CellTracker Green CMFDA Dye (C2925; Thermo
Scientiﬁc, USA) in DMEM lacking FBS and PS for 45 min. After
staining, the medium was replaced with fresh DMEM containing
10% FBS and 1% PS and the cells were incubated for 30 min. Stained
NHDFs were trypsinized, collected, and seeded in 12-well plates
(1.09  105 cells/well) containing hiPSCs. After 24 h, the medium
was removed and 1.63 mL 4-fold diluted mixed PAM was added to
the wells. Mixed PAM was removed after 6 h, and the cells were
washed twicewith PBS. Next, PI solution (P378; ﬁnal concentration,
15 mM; Dojindo) in PBS was added to the wells, and the cells were
incubated for 15min at 37 C in a CO2 incubator. The cells were then
washed twice with PBS and were observed under a ﬂuorescence
microscope (IX81; Olympus, Japan).
4.5. Quantiﬁcation of the selective killing ability of PAM
For this, 12-well plates were coatedwith 0.5 mg/cm2 laminin-511
E8 for 1 h at 37 C in a CO2 incubator, as described above. Varying
numbers of 201B7 hiPSCs (5.0 104, 2.5 104, and 1.25 104 cells)
were seeded in these plates. After 48 h, NHDFs were ﬂuorescently
labeled with 5 mM CellTracker Green CMFDA Dye in DMEM lacking
FBS and PS for 45 min at 37 C in a CO2 incubator. After staining, the
medium was replaced with fresh DMEM and the cells were incu-
bated for 30 min. Stained NHDFs were seeded (1.0  105 cells/well)
and were cocultured with 201B7 hiPSCs for 24 h. On the following
day, the medium was replaced with 1.5 mL fresh medium (Stemﬁt
AK03) or 1.5 mL 4-fold diluted PAM. After 48 h, the cells were
dissociated into single cells by treatment with 0.5 TrypLE Select
for 4 min at 37 C in a CO2 incubator. The cells were then collected
using a cell scraper and were centrifuged at 1500g for 1 min. After
removing supernatant, the cells were suspended in PBS containing
1% BSA. Finally, the cells were analyzed using a ﬂow cytometer
(Epics Altra; Beckman Coulter, USA).
4.6. Effect of PAM on hiPSC-derived differentiated cells
Schematic representation of this experiment is shown in Fig. 4A.
Four compartments of 35-mm dishes (627975; Greiner Bio-one)
were coated with 0.5 mg/cm2 laminin-511 E8 (iMatrix-511) for
1 h at 37 C in a CO2 incubator, as described above. Next, 201B7
hiPSCs were seeded (1.2  104 cells/compartment) in the
compartment with Stemﬁt AK03 medium containing the rock in-
hibitor (ﬁnal concentration, 10 mM) and were incubated for 24 h at
37 C in a CO2 incubator. On the following day, the medium was
replaced with fresh Stemﬁt AK03 medium containing 5 mM all-
trans RA (182-01111; Wako) to induce the differentiation of
201B7 hiPSCs. The differentiation medium was replaced every
alternate day. On the eighth day, undifferentiated 201B7 hiPSCs
were seeded (1.2 105 cells/compartment) in other compartments.
On the following day, themediumwas removed and 16-fold diluted
PAM was added to each compartments. After 24 h, PAM was
removed and the cells were washed 3 times with PBS. Next, 5 mMcalcein-AM and 3 mM PI solution in PBS were added to the dishes,
and the cells were incubated for 15 min at 37 C in a CO2 incubator.
After washing twice with PBS, the cells were observed under IX81
ﬂuorescence microscope.4.7. Real-time reverse transcription-PCR
For this, 35-mm dishes (3000-035; IWAKI, Japan) were coated
with 0.5 mg/cm2 laminin-511 E8 for 1 h at 37 C in a CO2 incubator,
as described above. Next, 201B7 hiPSCs were seeded
(9.0  104 cells/dish) in a compartment with the Stemﬁt AK03
medium containing the rock inhibitor (ﬁnal concentration, 10 mM)
and were incubated for 24 h at 37 C in a CO2 incubator. On the
following day, the cultivation medium was replaced with fresh
Stemﬁt AK03 medium to remove the rock inhibitor and the cells
were incubated for 48 h. Next, NHDFs were seeded (9.0  104 cells/
dish) in 35-mm dishes containing DMEM supplemented with 10%
FBS and 1% PS and were cultivated for 72 h. After 72 h, total RNA of
201B7 hiPSCs and NHDFs was extracted using Nucleospin RNA
(740955.50; MACHEREY-NAGEL, Germany) by following the man-
ufacturer's instructions. Purity and concentration of the extracted
RNA were determined using a spectrophotometer (V-730Bio;
JASCO CORPORATION, Japan) at 260 and 280 nm, respectively. First-
strand cDNA was prepared from the extracted RNA by using
ReverTra Ace qPCR RT Master Mix with gDNA Remover (FSQ-301;
TOYOBO, Japan) by following the manufacturer's instructions. Real-
Time PCR was performed using Eco Real-Time PCR system (Illu-
mina, USA), 0.4 mg cDNA, and THUNDERBIRD SYBR qPCR Mix (QPS-
201; TOYOBO). The conditions for real-time PCR were as follows:
(1) 95 C for 1 min, (2) 95 C for 15 s, (3) 60 C for 30 s, and (4) 45
cycles of (2) and (3). Melting curve was measured from 55 C to
95 C. Primers for PCR were purchased from FASMAC (Japan). Se-
quences of these primers are as follows: ATM forward: 50-
TTTACCTAACTGTGAGCTGTCTCCAT-30, ATM reverse: 50-ACTTCCG-
TAAGGCATCGTAACAC-30, SOD forward: 50-GAAGGTGTGGGGAAG-
CATTA-30, SOD reverse: 50-CAATAGACACATCGGCCACA-30, CAT
forward: 50-GCCTGGGACCCAATTATCTT-30, CAT reverse: 50-
GAATCTCCGCACTTCTCCAG-30, GPX1 forward: 50-CCAAGCTCAT-
CACCTGGTCT-30, GPX1 reverse: 50-TCGATGTCAATGGTCTGGAA-30,
GAPDH forward: 50-CCTGACCTGCCGTCTAGAAA-30, and GAPDH
reverse: 50-TGCTGTAGCCAAATTCGTTG-30.4.8. Statistical analysis
Data are presented as mean values and standard deviation (SD),
and a Student's t-test was used for evaluating statistical signiﬁcance
for comparison. A value less than 0.1, 0.05, 0.005 (*P < 0.1,
**P < 0.05, ***P < 0.005) indicated statistical signiﬁcance.Acknowledgement
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